ROYERSFORD, PA — Pinnaql, a portfolio company of 3 Boomerang Capital, acquired Pharma Resource Group as part of an ongoing expansion strategy aimed at building a larger life sciences consulting and advisory platform.
The transaction marks Pinnaql’s third acquisition in the past 10 months.
Pharma Resource Group, founded in 2007, provides analytical sciences, formulation, scientific writing, manufacturing, and change-control advisory services to pharmaceutical and life sciences companies.
Pinnaql said the acquisition expands its capabilities beyond engineering, regulatory compliance, validation, and quality systems consulting into additional areas of drug development and manufacturing support.
Chief Executive Officer John Duffin said the combined operations will allow the company to support clients across a broader range of product development and commercialization activities.
“By combining PRG’s scientific development and scale-up expertise with our established strengths in validation, engineering, quality systems, and regulatory compliance, we can now support clients throughout their full spectrum of growth,” Duffin said.
The acquisition follows Pinnaql’s earlier purchases, including Validation & Engineering Group Inc., as the company continues expanding its technical consulting and compliance services footprint.
Peter Wen, principal at 3 Boomerang Capital, said the deal strengthens Pinnaql’s position in the life sciences consulting market.
“PRG enhances the platform’s technical depth and further positions Pinnaql as a differentiated partner to life sciences organizations,” Wen said.
Financial terms of the acquisition were not disclosed.
Pinnaql provides regulatory, quality, and operational consulting services to biopharmaceutical, medical device, and contract development and manufacturing organizations worldwide.
3 Boomerang Capital, based in Fishers, Indiana, is a healthcare-focused private equity firm investing in lower-middle-market companies across North America and Western Europe. The firm said it is currently investing through its $376 million flagship fund.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.